To our knowledge, this study is the first to report that fibroblast growth factor-inducible protein 14 (FN14) expression and GRP94 expression in a patient diagnosed with breast cancer (BC) indicates a high risk of brain metastasis (BrM) progression, offering the opportunity to develop therapeutic strategies either to prevent the disease or facilitate early detection. This evidence concerns the gene TNFRSF12A and breast cancer.